| Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 3018 | 2017 |
| Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 2463 | 2017 |
| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1255 | 2021 |
| The epidemiology of age-related macular degeneration R Klein, T Peto, A Bird, MR Vannewkirk American journal of ophthalmology 137 (3), 486-495, 2004 | 1207 | 2004 |
| The lancet global health commission on global eye health: vision beyond 2020 MJ Burton, J Ramke, AP Marques, RRA Bourne, N Congdon, I Jones, ... The Lancet Global Health 9 (4), e489-e551, 2021 | 806 | 2021 |
| A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2 M Michaelides, A Kaines, RD Hamilton, S Fraser-Bell, R Rajendram, ... Ophthalmology 117 (6), 1078-1086. e2, 2010 | 706 | 2010 |
| Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ... The Lancet global health 9 (2), e130-e143, 2021 | 635 | 2021 |
| A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3 R Rajendram, S Fraser-Bell, A Kaines, M Michaelides, RD Hamilton, ... Archives of ophthalmology 130 (8), 972-979, 2012 | 526 | 2012 |
| Prevalence of age-related macular degeneration in Europe: the past and the future JM Colijn, GHS Buitendijk, E Prokofyeva, D Alves, ML Cachulo, ... Ophthalmology 124 (12), 1753-1763, 2017 | 515 | 2017 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 465 | 2021 |
| Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 … S Sivaprasad, AT Prevost, JC Vasconcelos, A Riddell, C Murphy, J Kelly, ... The Lancet 389 (10085), 2193-2203, 2017 | 389 | 2017 |
| Macular telangiectasia type 2 PC Issa, MC Gillies, EY Chew, AC Bird, TFC Heeren, T Peto, FG Holz, ... Progress in retinal and eye research 34, 49-77, 2013 | 386 | 2013 |
| Screening for diabetic retinopathy: new perspectives and challenges S Vujosevic, SJ Aldington, P Silva, C Hernández, P Scanlon, T Peto, ... The Lancet Diabetes & Endocrinology 8 (4), 337-347, 2020 | 361 | 2020 |
| Diabetic retinopathy: pathogenesis, clinical grading, management and future developments LZ Heng, O Comyn, T Peto, C Tadros, E Ng, S Sivaprasad, PG Hykin Diabetic Medicine 30 (6), 640-650, 2013 | 345 | 2013 |
| Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections RRA Bourne, JB Jonas, AM Bron, MV Cicinelli, A Das, SR Flaxman, ... British Journal of Ophthalmology 102 (5), 575-585, 2018 | 303 | 2018 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 282 | 2022 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 240 | 2022 |
| Redefining the overtraining syndrome as the unexplained underperformance syndrome R Budgett, E Newsholme, M Lehmann, C Sharp, D Jones, T Jones, T Peto, ... British Journal of Sports Medicine 34 (1), 67-68, 2000 | 238 | 2000 |
| Promising artificial intelligence-machine learning-deep learning algorithms in ophthalmology L Balyen, T Peto The Asia-Pacific Journal of Ophthalmology 8 (3), 264-272, 2019 | 229 | 2019 |
| Combining algorithms for automatic detection of optic disc and macula in fundus images RJ Qureshi, L Kovacs, B Harangi, B Nagy, T Peto, A Hajdu Computer Vision and Image Understanding 116 (1), 138-145, 2012 | 191 | 2012 |
